Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
In patients with resectable NSCLC, neoadjuvant nivolumab plus chemotherapy resulted in significantly longer event-free survival and a higher percentage of patients with a pathol...
Publications
2 shownAcquired Resistance to KRAS <sup>G12C</sup> Inhibition in Cancer
Diverse genomic and histologic mechanisms impart resistance to covalent KRAS<sup>G12C</sup> inhibitors, and new therapeutic strategies are required to delay and overcome this dr...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 3,156
- Institution
- Johns Hopkins University
External Links
Identifiers
- ORCID
- 0000-0003-0928-5244
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.